Retroperitoneale Residualtumorresektion nach Chemotherapie maligner
					Hodentumoren

P. Albers

doi:10.1055/s-0029-1233516

Aktuelle Urologie, Table of Contents

Aktuelle Urol 2012; 43(3): 197-206
DOI: 10.1055/s-0029-1233516

Operative Techniken

Retroperitoneale Residualtumorresektion nach Chemotherapie maligner Hodentumoren

P. Albers

¹Universitätsklinikum Düsseldorf, Urologische Klinik

› Author Affiliations

Abstract

Full Text

References

Literatur
1 Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. Eur Urol 2008; 53: 497-513
2 Albers P, Weissbach L, Krege S et al. German Testicular Cancer Study Group. Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group. J Urol 2004; 171: 1835-1838
3 Albers P, Ganz A, Hannig E et al. Salvage surgery of chemorefractory germ cell tumors with elevated tumor markers. J Urol 2000; 164: 381-384
4 Wahle GR, Foster RS, Bihrle R et al. Nerve sparing retroperitoneal lymphadenectomy after primary chemotherapy for metastatic testicular carcinoma. J Urol 1994; 152: 428-430
5 Fizazi K, Tjulandin S, Salvioni R et al. Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy-results from an international study group. J Clin Oncol 2001; 15: 2647-2657
6 Bachner M, Loriot Y, Gross-Goupil M et al. 2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial. Ann Oncol 2012; 23: 59-64
7 Winter C, Pfister D, Busch J et al. Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study Group. Eur Urol 2012; 61: 403-409
8 Albers P, Albrecht W, Algaba F et al. European Association of Urology. EAU guidelines on testicular cancer: 2011 update. Eur Urol 2011; 60: 304-319
9 Winter C, Albers P. Testicular germ cell tumors: pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 2011; 7: 43-53
10 Kollmannsberger C, Daneshmand S, So A et al. Management of disseminated nonseminomatous germ cell tumors with riskbased chemotherapy followed by response-guided postchemotherapy surgery. J Clin Oncol 2010; 28: 537-542
11 Ehrlich Y, Brames MJ, Beck SD et al. Long-term follow-up of Cisplatin combination chemotherapy in patients with disseminated nonseminomatous germ cell tumors: is a postchemotherapy retroperitoneal lymph node dissection needed after complete remission?. J Clin Oncol 2010; 28: 531-536